Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00572117 · ClinicalTrials.gov registry record · Phase 4
Adjunctive Topiramate for Treatment of Alcohol Dependence in Patients With Bipolar Disorder
A Phase 4 study, sponsored by Stanford University.
- Completed
- Registry status
- Phase 4
- Development phase
- 12
- Enrollment target
NCT00572117: Completed Phase 4 study, sponsored by Stanford University.
NCT00572117 is a Phase 4 study that has completed, run by Stanford University. The registered enrollment target is 12 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00572117, a Phase 4 study, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 12 participants
- Enrollment target
Study Summary
The purpose of this study is determine whether the use of topiramate is effective in the treatment of alcohol dependence (i.e. decreases drinking) in patients with bipolar disorder.
Interventions
- DRUG Topiramate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2007-08 |
| Est. Completion | 2014-07 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00572117
The ClinicalTrials.gov registry entry for NCT00572117 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Topiramate is the first listed.
NCT00572117 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00572117 about?
NCT00572117 is a clinical study titled "Adjunctive Topiramate for Treatment of Alcohol Dependence in Patients With Bipolar Disorder". The purpose of this study is determine whether the use of topiramate is effective in the treatment of alcohol dependence (i.e. decreases drinking) in patients with bipolar disorder.
What is the current status of trial NCT00572117?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 12 participants. The study started on 2007-08. Estimated completion is 2014-07.
What interventions are being tested in trial NCT00572117?
The interventions under investigation include: Topiramate (DRUG).
Who is sponsoring clinical trial NCT00572117?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.